Date	Subject
December 16, 1998	December 16, 1998 Cerus To Receive Funding From The Consortium For Plasma Science To Develop New Approach For Inactivating Pathogens In Human Blood Plasma For Fractionation
December 7, 1998	December 7, 1998 Cerus Commences Clinical Trials for Red Blood Cell Pathogen Inactivation Program
December 7, 1998	December 7, 1998 Preclinical Data Indicate Cerus Technology May Improve Bone Marrow Transplant Outcomes
December 7, 1998	December 7, 1998 Cerus Study Demonstrates Inactivation of Hepatitis B and C Viruses in Platelets
December 7, 1998	December 7, 1998 Cerus Study Demonstrates Inactivation of Hepatitis B and C Viruses in Platelets
December 3, 1998	December 3, 1998 Cerus Receives Clearance For Patient Study of its Fresh Frozen Plasma Pathogen Inactivation System
November 19, 1998	November 19, 1998 Cerus Completes Phase 2c Patient Study For Its Platelet Pathogen Inactivation System
October 21, 1998	October 21, 1998 Cerus Corporation Announces Third Quarter
July 22, 1998	July 22, 1998 Cerus Corporation Announces Second Quarter Results
July 15, 1998	July 15, 1998 Cerus Receives FDA Clearance for First Clinical Trial of a Pathogen Inactivation System for Red Blood Cells
July 8, 1998	July 8, 1998 Baxter Commits to $14.5 Million Cerus Financing and Earmarks Joint Development Funding
January 28, 1998	January 28, 1998 Cerus Corporation Announces Fourth Quarter and 1997 Results

Legal |
Privacy